You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

Select Your Country or Region
Send
COVID-19 Resource Center

Nyheder

Getinge Group Year-End Report 2014

PRESS RELEASE                                                                                                                                                                                                                                                                                    2015-01-28

Getinge Group Year-End Report 2014

Reporting period January – December

  • Order intake rose by 5.6% to SEK 26,817 M (25,395), and grew organically
    by 0.7%
  • Net sales increased by 5.5% to SEK 26,669 M (25,287), and grew organically
    by 0.6%
  • Profit before tax declined by 37.0% to SEK 1,987 M (3,153)
  • Net profit fell by 36.9% to SEK 1,448 M (2,295)
  • Earnings per share declined by 37.3% to SEK 6,01 (9,59)
  • EBITA before restructuring decreased by 5.6% to SEK 4,501 M (4,766)
  • Cash conversion from operating activities amounted to 72.9% (63.1%)
  • A dividend per share of SEK 2.80 (4.15) is proposed, corresponding to SEK 667 M (989)

Reporting period October - December

  • Order intake rose by 11.8% to SEK 7,747 M (6,931), and grew 3.0% organically
  • Net sales increased by 9.0% to SEK 8,458 M (7,757), and grew 1.1% organically
  • Profit before tax declined by 19.8% to SEK 1,371 M (1,709)
  • EBITA before restructuring declined by 3.2% to SEK 1,994 M (2,060)
  • Estimated financial consequences as a result of the discussions with the FDA are expected to have a negative impact of approximately SEK 500 M on operating profit, the entire amount of which will probably impact earnings for 2015. An additional SEK 175 M was recognized during the quarter for completing the remediation program, in addition to the SEK 820 M that was previously announced.
  • Alex Myers appointed new President and CEO of Getinge Group
  • Joacim Lindoff appointed new Executive Vice President of the Infection Control Business Area
Files

Del: